Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,222 | 163,873 | 16,274 | 23,695 | 16,064 |
| Marketable Securities | 124,233 | 61,983 | 68,219 | 74,363 | 93,975 |
| Receivables | 1,616 | 1,630 | 1,617 | 1,652 | 1,613 |
| Inventories | 4,850 | 2,686 | N/A | 0 | N/A |
| TOTAL | $216,130 | $232,262 | $88,121 | $100,853 | $112,657 |
| Non-Current Assets | |||||
| PPE Net | 10,338 | 9,489 | 6,947 | 4,430 | 4,058 |
| Other Non-Current Assets | 4,627 | 4,482 | 4,296 | 3,648 | 3,877 |
| TOTAL | $14,965 | $13,971 | $11,243 | $8,078 | $7,935 |
| Total Assets | $231,095 | $246,233 | $99,364 | $108,931 | $120,592 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,889 | 5,556 | 8,148 | 5,926 | 4,444 |
| Accounts payable and accrued liabilities | 5,927 | 7,337 | 5,018 | 3,441 | 7,710 |
| Accrued Expenses | 7,227 | 21,007 | 3,887 | 6,333 | 5,210 |
| Other current liabilities | 35 | 80 | 317 | 64 | 1 |
| TOTAL | $22,180 | $34,517 | $17,983 | $16,587 | $18,422 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,862 | 14,005 | 11,138 | 13,037 | 14,206 |
| Other Non-Current Liabilities | 26,820 | 34,135 | 28,847 | 35,276 | 42,191 |
| TOTAL | $37,682 | $48,140 | $39,985 | $48,313 | $56,397 |
| Total Liabilities | $59,862 | $82,657 | $57,968 | $64,900 | $74,819 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,191 | 51,279 | 51,157 | 48,534 | 43,471 |
| Common Shares | 524 | 512 | 490 | 457 | 434 |
| Retained earnings | -721,615 | -716,454 | -825,287 | -813,258 | -803,965 |
| Other shareholders' equity | 10 | -45 | -67 | 8 | -84 |
| TOTAL | $171,233 | $163,576 | $41,396 | $44,031 | $45,773 |
| Total Liabilities And Equity | $231,095 | $246,233 | $99,364 | $108,931 | $120,592 |